Johnson & Johnson offers up to $5.5bn to settle baby powder lawsuits

Johnson & Johnson has offered to pay up to $5.5 billion to settle a wave of lawsuits alleging that its talc-based products, most notably its iconic baby powder, cause cancer. This significant financial proposal marks a potential end to a protracted legal battle that has plagued the healthcare giant for years.

The company has consistently denied the allegations, maintaining that its talc products are safe and do not cause cancer. However, the sheer volume of lawsuits and the ongoing legal challenges have presented a substantial risk to the company. Thousands of plaintiffs claim that asbestos, a known carcinogen, was present in the talc used in Johnson & Johnson's products, leading to various cancers, including ovarian cancer and mesothelioma.

This proposed settlement, if accepted by the court and the majority of claimants, would bring closure to a deeply contentious issue. It represents a strategic move by Johnson & Johnson to manage its legal liabilities and move forward, though the exact terms and conditions of the settlement are still subject to finalization and court approval. The company's commitment to resolving these claims underscores the seriousness of the legal pressure it has faced.